| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Department of Diabetes and Endocrinology, Guys, Kings and St. Thomas School of Medicine, St. Thomas Hospital, London SE1 7EH, United Kingdom
Address all correspondence and requests for reprints to: Dr. James Gibney, Department of Endocrinology, Adelaide & Meath Hospitals, incorporating the National Childrens Hospital, Tallaght, Dublin 24, Ireland. E-mail: j.gibney{at}amnch.ie.
Context: Recombinant human-GH (r-hGH), in supraphysiological doses, is self-administered by athletes in the belief that it is performance enhancing.
Objective: The objective of this study was to determine whether r-hGH alters whole-body glucose and glycerol metabolism in endurance-trained athletes at rest and during and after exercise.
Design: This was a 4-wk double-blind placebo-controlled trial.
Setting: This study was conducted at St. Thomas Hospital (London, UK).
Participants: Twelve endurance-trained male athletes were recruited and randomized to r-hGH (0.2 U/kg·d) (n = 6) or identical placebo (n = 6) for 4 wk. One (placebo group) withdrew after randomization.
Intervention: Intervention was conducted by randomization to r-hGH (0.2 U/kg·d) or identical placebo for 4 wk.
Main Outcome Measures: Whole-body rates of appearance (Ra) of glucose and glycerol (an index of lipolysis) and rate of disappearance of glucose were measured using infusions of D-[66-2H2]glucose and 2H5-glycerol.
Results: Plasma levels of glycerol and free fatty acids and glycerol Ra at rest and during and after exercise increased during r-hGH treatment (P < 0.05 vs. placebo). Glucose Ra and glucose rate of disappearance were greater after exercise during r-hGH treatment (P < 0.05 vs. placebo). Resting energy expenditure and fat oxidation were greater under resting conditions during r-hGH treatment (P < 0.05 vs. placebo).
Conclusions: r-hGH in endurance-trained athletes increased lipolysis and fatty acid availability at rest and during and after exercise. r-hGH increased glucose production and uptake rates after exercise. The relevance of these effects for athletic performance is not known.
This article has been cited by other articles:
![]() |
H. Liu, D. M. Bravata, I. Olkin, A. Friedlander, V. Liu, B. Roberts, E. Bendavid, O. Saynina, S. R. Salpeter, A. M. Garber, et al. Systematic Review: The Effects of Growth Hormone on Athletic Performance Ann Intern Med, May 20, 2008; 148(10): 747 - 758. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Gibney, M.-L. Healy, and P. H. Sonksen The Growth Hormone/Insulin-Like Growth Factor-I Axis in Exercise and Sport Endocr. Rev., October 1, 2007; 28(6): 603 - 624. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Young, A. Anwar, and C. Milne Strong diabetes * COMMENTARY Br. J. Sports Med., May 1, 2007; 41(5): 335 - 336. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |